COVID-19 Immunity and Changes Over Time
NCT05271669 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1350
Last updated 2026-03-18
Summary
The risk of household spread of SARS-CoV-2 hinges on both the transmission dynamics of the virus circulating in the community as well as the seroprotection pattern of constituent members, which can be attributed to vaccination and previous infections. This study is conceptualised to assess the dynamicity of SARS-CoV-2 risk at the household level, through monitoring the pattern of seroprotection, in conjunction with the vaccination coverage, history of infection and exposure risk in the setting of Hong Kong.
Conditions
Sponsors & Collaborators
-
Chinese University of Hong Kong
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-06
- Primary Completion
- 2026-07-31
- Completion
- 2027-01-31
Countries
- China
Study Locations
More Related Trials
-
Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19
NCT04496141 ·Status: COMPLETED
-
Seroepidemiology of Viral Hepatitis in Hong Kong
NCT04371276 ·Status: COMPLETED
-
Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students
NCT01861613 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Long-term Impact Post COVID-19 for Patients and Health Care Professionals of the European Hospital
NCT04525911 ·Status: UNKNOWN
-
Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 Year
NCT04910971 ·Status: UNKNOWN
-
Epidemiological and Clinical Characteristics of Hospitalized Patients Under 5 Years Old With RSV Infection in Central China, Wuhan
NCT05767294 ·Status: ENROLLING_BY_INVITATION
-
Immune Dynamics in the Natural History of Chronic HBV Infection
NCT07137247 ·Status: RECRUITING
-
Safety and Immune Response of COVID-19 Vaccination in Patients With Chronic Liver Diseases
NCT05007665 ·Status: UNKNOWN
-
Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers
NCT04424017 ·Status: COMPLETED
-
Safety and Immunogenicity of COVID-19 Vaccine Booster in Patients With Liver Diseases
NCT05204602 ·Status: UNKNOWN
-
Using Mixed-methods Approach to Explore the Long-term Effects of COVID-19
NCT05303103 ·Status: COMPLETED
-
A Study to Evaluate Vaccines Against COVID-19 in the Real World
NCT04775056 ·Status: WITHDRAWN
-
RSV in Acute Respiratory Infection Surveillance Among Community-Dwelling Elderly Aged ≥50 Years in China
NCT07075029 ·Status: NOT_YET_RECRUITING
-
Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19 HCWs
NCT04563247 ·Status: COMPLETED
-
Pharmacogenomics Study on IL28B Genetic Variants in Chinese Children With Hepatitis C Virus Infection
NCT01607021 ·Status: UNKNOWN
-
Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection
NCT00688389 ·Status: UNKNOWN
-
Expression of Th9 Cells and Poor/Non-responsiveness to Hepatitis B Vaccination
NCT01441609 ·Status: UNKNOWN
-
Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict Study)
NCT05394623 ·Status: UNKNOWN
-
Effect of a Third COVID-19 Booster Among Health Care Workers
NCT05373459 ·Status: COMPLETED
-
SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the UZ Brussel Following COVID-19 Vaccination Using an Adenoviral Vector
NCT04939402 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prognostic Model of HCV-related Disease Progression After DAAs
NCT04631640 ·Status: UNKNOWN
-
Post-acute COVID-19 Sequelae in Denmark
NCT06191302 ·Status: RECRUITING
-
HCV Epidemiological Survey in China Rural Area
NCT04593355 ·Status: COMPLETED
-
Dynamic Changes of Monocytes and NK Cells of CHC Patient Treated by DAAs
NCT03063723 ·Status: COMPLETED
-
Immune Response in Patients With Hepatitis B and C Infection
NCT02275221 ·Status: RECRUITING